Literature DB >> 9570315

Domain 5 binds near a highly conserved dinucleotide in the joiner linking domains 2 and 3 of a group II intron.

M Podar1, J Zhuo, M Zhang, J S Franzen, P S Perlman, C L Peebles.   

Abstract

Photocrosslinking has identified the joiner between domains 2 and 3 [J(23)] as folding near domain 5 (D5), a highly conserved helical substructure of group II introns required for both splicing reactions. D5 RNAs labeled with the photocrosslinker 4-thiouridine (4sU) reacted with highly conserved nucleotides G588 and A589 in J(23) of various intron acceptor transcripts. These conjugates retained some ribozyme function with the lower helix of D5 crosslinked to J(23), so they represent active complexes. One partner of the gamma x gamma' tertiary interaction (A587 x U887) is also in J(23); even though gamma x gamma' is involved in step 2 of the splicing reaction, D5 has not previously been found to approach gamma x gamma'. Similar crosslinking patterns between D5 and J(23) were detected both before and after step 1 of the reaction, indicating that the lower helix of D5 is positioned similarly in both conformations of the active center. Our results suggest that the purine-rich J(23) strand is antiparallel to the D5 strand containing U32 and U33. Possibly, the interaction with J(23) helps position D5 correctly in the ribozyme active site; alternatively, J(23) itself might participate in the catalytic center.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9570315      PMCID: PMC1369604     

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  38 in total

1.  Site-specific cross-linking of mammalian U5 snRNP to the 5' splice site before the first step of pre-mRNA splicing.

Authors:  J R Wyatt; E J Sontheimer; J A Steitz
Journal:  Genes Dev       Date:  1992-12       Impact factor: 11.361

2.  Excised group II introns in yeast mitochondria are lariats and can be formed by self-splicing in vitro.

Authors:  R van der Veen; A C Arnberg; G van der Horst; L Bonen; H F Tabak; L A Grivell
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

3.  Identification of structural elements critical for inter-domain interactions in a group II self-splicing intron.

Authors:  J L Jestin; E Dème; A Jacquier
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

4.  Spliceosomal RNA U6 is remarkably conserved from yeast to mammals.

Authors:  D A Brow; C Guthrie
Journal:  Nature       Date:  1988-07-21       Impact factor: 49.962

5.  Group II intron domain 5 facilitates a trans-splicing reaction.

Authors:  K A Jarrell; R C Dietrich; P S Perlman
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

6.  Nucleosides and nucleotides. VI. Preparation of diribonucleoside monophosphates containing 4-thiouridine.

Authors:  K Miura; M Shiga; T Ueda
Journal:  J Biochem       Date:  1973-06       Impact factor: 3.387

7.  A self-splicing RNA excises an intron lariat.

Authors:  C L Peebles; P S Perlman; K L Mecklenburg; M L Petrillo; J H Tabor; K A Jarrell; H L Cheng
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

8.  Group II intron self-splicing. Alternative reaction conditions yield novel products.

Authors:  K A Jarrell; C L Peebles; R C Dietrich; S L Romiti; P S Perlman
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

9.  The U5 and U6 small nuclear RNAs as active site components of the spliceosome.

Authors:  E J Sontheimer; J A Steitz
Journal:  Science       Date:  1993-12-24       Impact factor: 47.728

10.  Domain 5 interacts with domain 6 and influences the second transesterification reaction of group II intron self-splicing.

Authors:  S D Dib-Hajj; S C Boulanger; S K Hebbar; C L Peebles; J S Franzen; P S Perlman
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

View more
  13 in total

1.  Visualizing the solvent-inaccessible core of a group II intron ribozyme.

Authors:  J Swisher; C M Duarte; L J Su; A M Pyle
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

2.  A tertiary interaction detected in a human U2-U6 snRNA complex assembled in vitro resembles a genetically proven interaction in yeast.

Authors:  S Valadkhan; J L Manley
Journal:  RNA       Date:  2000-02       Impact factor: 4.942

3.  Tight binding of the 5' exon to domain I of a group II self-splicing intron requires completion of the intron active site.

Authors:  M Costa; F Michel
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

4.  Deletion of a conserved dinucleotide inhibits the second step of group II intron splicing.

Authors:  S Mikheeva; H L Murray; H Zhou; B M Turczyk; K A Jarrell
Journal:  RNA       Date:  2000-11       Impact factor: 4.942

5.  A conjugation-based system for genetic analysis of group II intron splicing in Lactococcus lactis.

Authors:  Joanna R Klein; Yuqing Chen; Dawn A Manias; Jin Zhuo; Liang Zhou; Craig L Peebles; Gary M Dunny
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

6.  Three essential and conserved regions of the group II intron are proximal to the 5'-splice site.

Authors:  Alexandre de Lencastre; Anna Marie Pyle
Journal:  RNA       Date:  2007-11-26       Impact factor: 4.942

7.  A glimpse into the active site of a group II intron and maybe the spliceosome, too.

Authors:  Kwaku T Dayie; Richard A Padgett
Journal:  RNA       Date:  2008-07-24       Impact factor: 4.942

8.  Crystal structure of a self-spliced group II intron.

Authors:  Navtej Toor; Kevin S Keating; Sean D Taylor; Anna Marie Pyle
Journal:  Science       Date:  2008-04-04       Impact factor: 47.728

9.  A map of the binding site for catalytic domain 5 in the core of a group II intron ribozyme.

Authors:  B B Konforti; Q Liu; A M Pyle
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

10.  Differential chemical probing of a group II self-splicing intron identifies bases involved in tertiary interactions and supports an alternative secondary structure model of domain V.

Authors:  M Costa; E L Christian; F Michel
Journal:  RNA       Date:  1998-09       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.